The National Institute on Drug Abuse is offering a grant to support the clinical development of minimally-invasive bioassays for outpatient clinical trials of therapeutics for Substance Use Disorders (SUDs). This grant aims to fund projects that focus on the advancement of non-invasive methods to facilitate the testing of pharmacotherapies for SUDs. Deadline for applications is January 24, 2018.
Opportunity ID: 280873
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-16-075 |
Funding Opportunity Title: | Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Jan 08, 2016 |
Last Updated Date: | Nov 27, 2017 |
Original Closing Date for Applications: | Sep 07, 2018 |
Current Closing Date for Applications: | Jan 24, 2018 |
Archive Date: | Feb 23, 2018 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments County governments Native American tribal governments (Federally recognized) Small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses State governments Independent school districts Special district governments Public housing authorities/Indian housing authorities Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) encourages Research Project Grant (R21) applications from institutions/ organizations that propose to develop non-invasive methods to support outpatient clinical trials of pharmacotherapies for Substance Use Disorders (SUDs). |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-16-075.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
This FOA has been reissued and will close on January 24, 2018. Applicants must use reissued FOA with FORMS-E application forms for due dates on or after January 25, 2018 | Nov 27, 2017 | |
Nov 27, 2017 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-16-075 |
Funding Opportunity Title: | Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Jan 08, 2016 |
Last Updated Date: | Nov 27, 2017 |
Original Closing Date for Applications: | Sep 07, 2018 |
Current Closing Date for Applications: | Jan 24, 2018 |
Archive Date: | Feb 23, 2018 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments County governments Native American tribal governments (Federally recognized) Small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses State governments Independent school districts Special district governments Public housing authorities/Indian housing authorities Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) encourages Research Project Grant (R21) applications from institutions/ organizations that propose to develop non-invasive methods to support outpatient clinical trials of pharmacotherapies for Substance Use Disorders (SUDs). |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-16-075.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-16-075 |
Funding Opportunity Title: | Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 27, 2017 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Sep 07, 2018 |
Archive Date: | Oct 08, 2018 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Native American tribal governments (Federally recognized) Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Independent school districts County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses For profit organizations other than small businesses Special district governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) encourages Research Project Grant (R21) applications from institutions/ organizations that propose to develop non-invasive methods to support outpatient clinical trials of pharmacotherapies for Substance Use Disorders (SUDs). |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-16-075.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-C | FORMS-C | PKG00220378 | Jan 16, 2016 | May 07, 2016 | View | |
FORMS-D | Use for due dates on or before January 24, 2018 | PKG00222526 | Apr 17, 2016 | Jan 24, 2018 | View |
Package 1
Mandatory forms
280873 RR_SF424_2_0-2.0.pdf
280873 PHS398_ResearchPlan_2_0-2.0.pdf
280873 PHS398_CoverPageSupplement_2_0-2.0.pdf
280873 RR_KeyPersonExpanded_2_0-2.0.pdf
280873 RR_OtherProjectInfo_1_3-1.3.pdf
280873 PerformanceSite_2_0-2.0.pdf
Optional forms
280873 RR_SubawardBudget30_1_3-1.3.pdf
280873 PlannedReport-1.0.pdf
280873 PHS398_CumulativeInclusionReport-1.0.pdf
280873 PHS398_ModularBudget_1_2-1.2.pdf
280873 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
280873 RR_SF424_2_0-2.0.pdf
280873 PHS398_CoverPageSupplement_3_0-3.0.pdf
280873 RR_OtherProjectInfo_1_3-1.3.pdf
280873 PerformanceSite_2_0-2.0.pdf
280873 RR_KeyPersonExpanded_2_0-2.0.pdf
280873 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
280873 RR_Budget_1_3-1.3.pdf
280873 RR_SubawardBudget30_1_3-1.3.pdf
280873 PHS398_ModularBudget_1_2-1.2.pdf
280873 PHS_Inclusion_Enrollment_Report-1.0.pdf
280873 PHS_AssignmentRequestForm-1.0.pdf